Skip to content
← Full study record

NCT02912559 · MORE INFO

Limitations, agreements, and source contact

Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair · Source last updated 2026-10-01

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement
pi Sponsor Employee
false
restriction Type
LTE60
restrictive Agreement
true
point Of Contact
email
sinicrope.frank@mayo.edu
organization
Mayo Clinic
phone
507-266-5365
title
Frank A. Sinicrope, MD
Complete source fields
certain Agreement
pi Sponsor Employee
false
restriction Type
LTE60
restrictive Agreement
true
point Of Contact
email
sinicrope.frank@mayo.edu
organization
Mayo Clinic
phone
507-266-5365
title
Frank A. Sinicrope, MD

Download exact source JSON → · Snapshot ctgov-results-aad7e863b8b06225cd4e94e7

Preserved source evidence · Not medical advice